Skip to content
Back to meeting Original
Jose Fernando Moura, PhD· @FernandoOnco · X·· 15 hours agoScore70

SANOVO

Body · original

SANOVO - New strategy to overcome MET resistance in mEGFR NSCLC
Savolitinib + Osi
Side effects are the concern
Strong signal in survival
@myESMO #ESMO26 @OncoAlert @HHorinouchi

20 views · 0 likes · 0 reposts · 0 replies

Source: Jose Fernando Moura, PhD · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.